PuraPharm Corporation Limited reported unaudited consolidated cash flow results for the six months ended June 30, 2017. For the six months, the company's net cash used in operating activities was HKD 81,476,000 against HKD 40,275,000 a year ago. Purchases of property, plant and equipment was HKD 35,436,000 against HKD 21,632,000 a year ago. Addition to other intangible assets was HKD 5,065,000 against HKD 13,493,000 a year ago.